BIOLIFESAS LTD

Company Registration Number:
14164424 (England and Wales)

Unaudited statutory accounts for the year ended 30 June 2023

Period of accounts

Start date: 10 June 2022

End date: 30 June 2023

BIOLIFESAS LTD

Contents of the Financial Statements

for the Period Ended 30 June 2023

Directors report
Profit and loss
Balance sheet
Additional notes

BIOLIFESAS LTD

Directors' report period ended 30 June 2023

The directors present their report with the financial statements of the company for the period ended 30 June 2023

Principal activities of the company

58110 - Book publishing58120 - Publishing of directories and mailing lists58141 - Publishing of learned journals58142 - Publishing of consumer and business journals and periodicals



Directors

The director shown below has held office during the whole of the period from
10 June 2022 to 30 June 2023

Xiaoming SHI


The director shown below has held office during the period of
10 June 2022 to 1 June 2023

Keith Yunxi ZHU


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
1 March 2024

And signed on behalf of the board by:
Name: Xiaoming SHI
Status: Director

BIOLIFESAS LTD

Profit And Loss Account

for the Period Ended 30 June 2023

13 months to 30 June 2023


£
Turnover: 3,910,748
Cost of sales: ( 3,904,457 )
Gross profit(or loss): 6,291
Operating profit(or loss): 6,291
Profit(or loss) before tax: 6,291
Profit(or loss) for the financial year: 6,291

BIOLIFESAS LTD

Balance sheet

As at 30 June 2023

Notes 13 months to 30 June 2023


£
Called up share capital not paid: 0
Fixed assets
Intangible assets:   0
Tangible assets:   0
Investments:   0
Total fixed assets: 0
Current assets
Debtors:   0
Cash at bank and in hand: 6,290
Investments:   0
Total current assets: 6,290
Prepayments and accrued income: 0
Creditors: amounts falling due within one year:   0
Net current assets (liabilities): 6,290
Total assets less current liabilities: 6,290
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): 6,290
Capital and reserves
Called up share capital: 5,000
Share premium account: 0
Other reserves: 0
Profit and loss account: 1,290
Total Shareholders' funds: 6,290

The notes form part of these financial statements

BIOLIFESAS LTD

Balance sheet statements

For the year ending 30 June 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 1 March 2024
and signed on behalf of the board by:

Name: Xiaoming SHI
Status: Director

The notes form part of these financial statements

BIOLIFESAS LTD

Notes to the Financial Statements

for the Period Ended 30 June 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BIOLIFESAS LTD

Notes to the Financial Statements

for the Period Ended 30 June 2023

  • 2. Employees

    13 months to 30 June 2023
    Average number of employees during the period 1